USPTO serial 79222989
LIFEARC
Reviewed by CopyMark Law Group
Reg. 5624714Status 708Registered
- Filing date
- Status date
- Registration date
- Dec 11, 2018
- Examiner
- LAMONT, JOHN CHRISTOPHER
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with LIFEARC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Britt L. Anderson
Britt L. Anderson Ashurst Perkins Coie US LLP3150 Porter Dr.Palo Alto, CA 94304United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | [ Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, and brochures about a biomedical and scientific research facility; downloadable electronic educational and professional podcasts and webcasts featuring information about biomedical and scientific research on human health and human diseases ] | SECTION 71 - CANCELLED | — |
| 016 | [ Printed educational and professional publications, namely, newsletters, fact sheets, and brochures about biomedical and scientific research and information about biomedical and scientific research on human health and human diseases ] | SECTION 71 - CANCELLED | — |
| 035 | Promoting research in the field of human health and human diseases through the support and coordination of research projects conducted by universities, hospitals, research foundations and businesses; business consultation services in the nature of providing advisory, consultancy and information services in the field of commercialisation of products and services by identifying routes to market for research; compilation of scientific, medical and clinical information into computer databases | ACTIVE | — |
| 036 | [ Charitable fund raising; charitable fundraising collections; organisation of collections in the nature of charitable fundraising; ] charitable services, namely, provision of funding for research, education, prevention, diagnosis and treatment of illnesses and human diseases; financial grant services, namely, providing grants for research, education, prevention, diagnosis, and treatment of illnesses and human diseases; provision of funding for charities in the nature of philanthropic services concerning monetary donations; [ charitable services, namely, provision of funding for medical trials; ] charitable services, namely, provision of funding for educational and research posts; information and advisory services relating to all the aforesaid [ ; intellectual property venture fund development and formation services for others enabling inventors of new technology to secure appropriate funding for continued technological development; technology transfer services, namely, financial asset management in the nature of managing revenue from partnered or developed intellectual property ] | ACTIVE | — |
| 041 | Providing educational, training and mentoring services concerning the causes, prevention, detection, diagnosis, and treatment of diseases through conferences, seminars and written materials disseminated in connection therewith | ACTIVE | — |
| 042 | Scientific [ , medical and clinical ] research services; scientific research and analysis in the field of biotechnology; scientific research and analysis in the field of biochemistry; scientific research and analysis in the field of biology; [ conducting clinical trials for others; ] data mining; [ data security consultancy services; data encryption services; ] database design and development; [ maintenance of computer software for databases; mathematical modelling services; ] scientific and technological services, namely, scientific research and analysis in the field of bioinformatics; drug discovery services; laboratory research in the field of medicine; [ computer programming and software design services; ] consultancy services relating to all of the foregoing; scientific research and development in the field of medical technology; research on the development and adaptation of health technology and health-related outcomes associated with implementation of health technology; [ clinical research services, namely, collection, calibration, analysis and reporting of data in connection with clinical trials; conducting clinical trials for others for diagnostic tests and for pharmaceutical preparations; ] sproviding temporary use of non-downloadable web-based computer software in the fields of medicine and biotechnology for data integration, exchange, and analysis in the nature of a collaborative research management platform; providing biomedical and scientific information via a global internet web site related to the field of human health and human diseases; technology transfer services, namely, new product design and development services; scientific research and development; product development; antibody humanisation services, namely, antibody engineering in the nature of antibody research and development services; biopharmaceutical product development; biologic assay product development; medical research, namely, preclinical research [ ; clinical research in the fields of genetic disorders and infectious diseases; consulting services for others in the design and planning of project management of clinical trials; testing and inspection of pharmaceuticals in the nature of pharmacovigilance, namely, monitoring the effects of medical drugs after they have been licensed for use ] | ACTIVE | — |
| 044 | Pharmaceutical treatment diagnostics in the nature of medical and pharmaceutical consultation [ ; medical services; advice on medical information relating to alleviation, diagnosis, prevention and treatment of illnesses and human diseases ] | ACTIVE | — |
| 045 | [ Legal services; ] licensing of technology, namely, patent licensing; licensing and intellectual property services in relation to technology transfer services, namely, consulting in the field of intellectual property | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LIFEARC
- Other trademarks owned by LIFEARC
- Other trademarks owned by LIFEARC
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named LIFEARC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 1, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 10, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 8, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 8, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 6, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 6, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| May 6, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| May 6, 2025 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| May 6, 2025 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| May 6, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| May 6, 2025 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 7, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 6, 2024 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jan 19, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 11, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 12, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 21, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 21, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 11, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 11, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 25, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 25, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 21, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 5, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 5, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 5, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 24, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 16, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 15, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 15, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 15, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 15, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 31, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 24, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jul 10, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 10, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 5, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 5, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 27, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 18, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 11, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 11, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 22, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 22, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 21, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 18, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 14, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |